📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Pharmacological inhibition of Hippo pathway, with the novel kinase inhibitor XMU-MP-1, protects the heart against adverse effects during pressure overload. (2019)

First Author: Triastuti E

Attributed to: The role of plasma membrane calcium ATPase 4 (PMCA4) in modulating Plasmodium infection and malaria severity funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bph.14795

PubMed Identifier: 31328787

Publication URI: http://europepmc.org/abstract/MED/31328787

Type: Journal Article/Review

Volume: 176

Parent Publication: British journal of pharmacology

Issue: 20

ISSN: 0007-1188